The VA psilocybin PTSD/TRD trials will publish only enrollment/protocol details — no efficacy data — on ClinicalTrials.gov within 10 weeks.

Predicted 2026-08-15 · Resolves 2026-10-24 · clinical · USA

80%

ORACLE CONFIDENCE

⏳ Pending

Every outcome is scored publicly in the ledger.

The US Department of Veterans Affairs has started clinical trials testing psilocybin (the active compound in 'magic mushrooms') for PTSD and hard-to-treat depression in veterans. By late October 2026, the public trial registry will only show details about how the study is set up and how many people are enrolling — not whether the treatment actually works. This is completely normal for new trials, but it means no answers for veterans anytime soon.

Resolution rule: YES if, on 2026-10-24, the VA psilocybin PTSD/TRD trial record(s) on clinicaltrials.gov show status/enrollment/protocol information only, with NO posted results (efficacy outcome) section. Checked at clinicaltrials.gov for the relevant VA-sponsored psilocybin trial NCT record(s). Resolves NO if any efficacy results are posted.

Newly launched trials are years from readout; launch ≠ evidence. This is a near-term, precisely checkable registry-status prediction distinguishing recruitment activity from outcome data.

5 new falsifiable predictions, every day at 12:05 PM ET.

Get tomorrow's Oracle →